Literature DB >> 20553314

Safety and efficacy of laparoscopic ventral mesh rectopexy for complex rectocele.

M Wong1, G Meurette, E Abet, J Podevin, P A Lehur.   

Abstract

AIM: Laparoscopic ventral mesh rectopexy, previously described for external rectal prolapse, was evaluated for symptomatic complex rectocoele.
METHOD: From January 2004 to December 2008, 84 (50.9%) patients (mean age 64 ± 5 years) underwent laparoscopic ventral mesh rectopexy for symptomatic complex rectocoele, confirmed preoperatively on dynamic defaecography, with 26 (31%) patients having a concurrent cystocoele. The operative technique was standardized, and those with cystocoele underwent bladder mesh suspension during the same procedure. Prospectively collected data were analysed for preoperative symptoms, operative and functional results [constipation, faecal incontinence (FI), dyspareunia and satisfaction score].
RESULTS: The conversion rate was 3.6% and perioperative morbidity 4.8% with no mortality. At a median follow up of 29 (4-59) months, there was a significant decrease in vaginal discomfort (86-20%) and obstructed defaecation symptoms (83-46%), P < 0.001. There was no significant change in FI (20-16%), no worsening of preoperative symptoms or new complaints of constipation, dyspareunia or FI. Overall, 88% of patients reported an improvement in overall well-being.
CONCLUSION: Laparoscopic ventral mesh rectopexy is a safe and effective method for treating symptomatic complex rectocoele.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2010        PMID: 20553314     DOI: 10.1111/j.1463-1318.2010.02349.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  22 in total

1.  Modified laparoscopic ventral mesh rectopexy.

Authors:  P Sileri; I Capuano; L Franceschilli; F Giorgi; A L Gaspari
Journal:  Tech Coloproctol       Date:  2013-11-21       Impact factor: 3.781

Review 2.  Is robotic ventral mesh rectopexy better than laparoscopy in the treatment of rectal prolapse and obstructed defecation? A meta-analysis.

Authors:  L Ramage; P Georgiou; P Tekkis; E Tan
Journal:  Tech Coloproctol       Date:  2015-06-04       Impact factor: 3.781

Review 3.  The role of synthetic and biologic materials in the treatment of pelvic organ prolapse.

Authors:  Ramon A Brown; C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2014-12

4.  Erosion versus recurrence: is there a compromise using biologics for ventral rectopexy?

Authors:  A R L Stevenson
Journal:  Tech Coloproctol       Date:  2015-03-03       Impact factor: 3.781

5.  Laparoscopic ventral rectopexy: a prospective long-term evaluation of functional results and quality of life.

Authors:  L Maggiori; F Bretagnol; M Ferron; Y Panis
Journal:  Tech Coloproctol       Date:  2013-01-23       Impact factor: 3.781

6.  Case-matched series of a non-cross-linked biologic versus non-absorbable mesh in laparoscopic ventral rectopexy.

Authors:  James W Ogilvie; Andrew R L Stevenson; Michael Powar
Journal:  Int J Colorectal Dis       Date:  2014-10-15       Impact factor: 2.571

Review 7.  [Rectocele : Symptoms, diagnostics and therapy concepts from a coloproctological viewpoint].

Authors:  O Schwandner
Journal:  Chirurg       Date:  2016-11       Impact factor: 0.955

Review 8.  Current status of laparoscopic and robotic ventral mesh rectopexy for external and internal rectal prolapse.

Authors:  Jan J van Iersel; Tim J C Paulides; Paul M Verheijen; John W Lumley; Ivo A M J Broeders; Esther C J Consten
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

Review 9.  Evolution of laparoscopy in colorectal surgery: an evidence-based review.

Authors:  Alexander Emmanuel Blackmore; Mark Te Ching Wong; Choong Leong Tang
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

10.  Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment).

Authors:  Antonio Bove; Massimo Bellini; Edda Battaglia; Renato Bocchini; Dario Gambaccini; Vincenzo Bove; Filippo Pucciani; Donato Francesco Altomare; Giuseppe Dodi; Guido Sciaudone; Ezio Falletto; Vittorio Piloni
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.